Neuromod Closes €10 Million Financing to Accelerate Commercialization of Lenire
Neuromod Devices Ltd. has secured €10 million in oversubscribed equity financing to expand the availability of its FDA-approved tinnitus treatment device, Lenire.
Neuromod Devices Ltd. has secured €10 million in oversubscribed equity financing to expand the availability of its FDA-approved tinnitus treatment device, Lenire.
To mark World Hearing Day 2025, the WHO and ITU have introduced the first global standard for safe listening in video gaming and esports, aiming to prevent hearing loss among gamers by implementing protective features in gaming devices and software.
The Hearing Review’s Chief Editor Melanie Hamilton-Basich sat down with Angela Bonino, PhD, a...
Tricare provides hearing aid coverage for eligible children of retired service members, enhancing access to essential auditory care.
Researchers identified a key driver of susceptibility to "glue ear" in individuals with Down syndrome, paving the way for targeted therapies to address hearing loss.
Tinnitus is a common condition that can be difficult for hearing care professionals to treat and manage. MedRx makes it easier with a new test available in MedRx Studio software.
Clinical suggestions that can help people in both roles improve their ability to monitor their music and extend their performing careers.
Celesta is a next-generation two-channel system designed for comprehensive auditory and vestibular evoked potential testing.
A study of veterans suggests a link between hearing loss and risk of Parkinson’s disease, with hearing aids potentially reducing this risk.